WinRHO is used as a prophylactic treatment in pregnancies when the mother's blood type is Rh-negative. This prevents the formation of antibodies that might attack the fetus's blood if it is Rh-positive. This preparation works to prevent an immune reaction that could lead to serious complications such as fetal red blood cell destruction and severe anemia. This preventative measure is important for protecting the current and future pregnancies.
WinRHO helps treat immune thrombocytopenia in Rh-positive individuals, as it helps increase platelet counts and reduce the risk of bleeding, especially in cases where splenectomy is not possible. This treatment must be used under direct medical supervision, with close monitoring to avoid any potential side effects and ensure the desired benefit is achieved without complications.